Literature DB >> 28614699

A signal amplification probe enhances sensitivity of antibodies and aptamers based Immuno-diagnostic assays.

Ofer Nussbaum1, Michal Bar Oz1, Tal Tilayov1, Helly Atiya1, Shlomo Dagan2.   

Abstract

One major unmet need is improving the sensitivity of immune-diagnostic assays. This is particularly important in the field of biomarker discoveries and monitoring. We have established a novel signal amplification probe system enabling a highly sensitive target detection platform to be used in immuno-assays. The probe consists of a double stranded DNA that can carry a large number of signaling elements such as biotin or fluorescent molecules. The DNA probe anchors to the recognition unit, whether an antibody or an aptamer, by covalent conjugation or by a simple and rapid molecular association process. Binding curves obtained by using the DNA amplification probe are dose dependent and linear over a wide range of antigen concentration. The optimal slopes are characterized by high signals and low background increasing the assay sensitivity and reducing the limit of detection by up to 10-fold compared to biotinylated antibodies commonly used in ELISA systems. When using aptamers in combination with the amplification probe for antigen recognition, the limit of detection is comparable to that obtained by biotinylated antibodies. Biotin labeled aptamers practically cannot be used for detection of low target levels. The DNA amplification probe system enables to expand the range of diagnostic assays including clinical samples and meet research needs.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28614699     DOI: 10.1016/j.jim.2017.06.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  1 in total

Review 1.  Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review.

Authors:  Navid Rabiee; Sepideh Ahmadi; Zeynab Arab; Mojtaba Bagherzadeh; Moein Safarkhani; Behzad Nasseri; Mohammad Rabiee; Mohammadreza Tahriri; Thomas J Webster; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2020-06-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.